Preprint · OA via OpenAlex

Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis

James M. Walter, Lorraine B. Ware, Michael A. Matthay

The Lancet Respiratory Medicine · 2014 · ▲ 284 citations

Stem-cell exhaustion Stem-cell therapy

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1016/s2213-2600(14)70217-6
Canonical: link ↗
Fetched: 2026-06-21 MST

Cite this

APA

Walter, J.M., Ware, L.B., & Matthay, M.A. (2014). Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis. <em>The Lancet Respiratory Medicine</em>. https://doi.org/10.1016/s2213-2600(14)70217-6

Vancouver

Walter JM, Ware LB, Matthay MA. Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis. The Lancet Respiratory Medicine. 2014. doi:10.1016/s2213-2600(14)70217-6.

BibTeX

@unpublished{james2014Mesenc, title = {Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis}, author = {James M. Walter and Lorraine B. Ware and Michael A. Matthay}, journal = {The Lancet Respiratory Medicine}, year = {2014}, doi = {10.1016/s2213-2600(14)70217-6}, }